188 related articles for article (PubMed ID: 26640079)
21. Safety of botulinum toxin A in children and adolescents with cerebral palsy in a pragmatic setting.
Papavasiliou AS; Nikaina I; Foska K; Bouros P; Mitsou G; Filiopoulos C
Toxins (Basel); 2013 Mar; 5(3):524-36. PubMed ID: 23482250
[TBL] [Abstract][Full Text] [Related]
22. The influence of physical therapy and anti-botulinum toxin antibody on the efficacy of botulinum toxin-A injections in children with spastic cerebral palsy.
Jang DH; Sung IY
Dev Neurorehabil; 2014 Dec; 17(6):414-9. PubMed ID: 25372070
[TBL] [Abstract][Full Text] [Related]
23. Safety profile of incobotulinum toxin A [Xeomin(®)] in gastrocnemious muscles injections in children with cerebral palsy: Randomized double-blind clinical trial.
Carraro E; Trevisi E; Martinuzzi A
Eur J Paediatr Neurol; 2016 Jul; 20(4):532-7. PubMed ID: 27177451
[TBL] [Abstract][Full Text] [Related]
24. Safety of Botulinum Toxin Type A for Children With Nonambulatory Cerebral Palsy.
Edwards P; Sakzewski L; Copeland L; Gascoigne-Pees L; McLennan K; Thorley M; Kentish M; Ware R; Boyd RN
Pediatrics; 2015 Nov; 136(5):895-904. PubMed ID: 26482662
[TBL] [Abstract][Full Text] [Related]
25. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy.
Wasiak J; Hoare B; Wallen M
Cochrane Database Syst Rev; 2004 Oct; (4):CD003469. PubMed ID: 15495055
[TBL] [Abstract][Full Text] [Related]
26. Severity of cerebral palsy and likelihood of adverse events after botulinum toxin A injections.
Swinney CM; Bau K; Burton KLO; O'Flaherty SJ; Bear NL; Paget SP
Dev Med Child Neurol; 2018 May; 60(5):498-504. PubMed ID: 29451702
[TBL] [Abstract][Full Text] [Related]
27. Muscle volume alterations after first botulinum neurotoxin A treatment in children with cerebral palsy: a 6-month prospective cohort study.
Alexander C; Elliott C; Valentine J; Stannage K; Bear N; Donnelly CJ; Shipman P; Reid S
Dev Med Child Neurol; 2018 Nov; 60(11):1165-1171. PubMed ID: 30151852
[TBL] [Abstract][Full Text] [Related]
28. Sedation with intravenous ketamine and midazolam for painful procedures in children.
Karapinar B; Yilmaz D; Demirağ K; Kantar M
Pediatr Int; 2006 Apr; 48(2):146-51. PubMed ID: 16635173
[TBL] [Abstract][Full Text] [Related]
29. Question 2: is there any long-term benefit from injecting botulinum toxin-A into children with cerebral palsy?
Bradley LJ; Huntley JS
Arch Dis Child; 2014 Apr; 99(4):392-4. PubMed ID: 24626322
[No Abstract] [Full Text] [Related]
30. Determining the technical and clinical factors associated with pain for children undergoing botulinum toxin injections under nitrous oxide and anesthetic cream.
Brochard S; Blajan V; Lempereur M; Garlantezec R; Houx L; Le Moine P; Peudenier S; Lefranc J; Rémy-Néris O
Eur J Paediatr Neurol; 2011 Jul; 15(4):310-5. PubMed ID: 21273098
[TBL] [Abstract][Full Text] [Related]
31. Application of botulinum toxin in treatment of spasticity and functional improvements for children suffering from cerebral palsy.
Meholjic A; Madjar D
Med Arh; 2010; 64(6):359-61. PubMed ID: 21218755
[TBL] [Abstract][Full Text] [Related]
32. Botulinum Toxin Type A Injection for Spastic Equinovarus Foot in Children with Spastic Cerebral Palsy: Effects on Gait and Foot Pressure Distribution.
Choi JY; Jung S; Rha DW; Park ES
Yonsei Med J; 2016 Mar; 57(2):496-504. PubMed ID: 26847306
[TBL] [Abstract][Full Text] [Related]
33. Botulinum Toxin: Techniques Within Pediatric Physiatry.
Paulson A; Zigler CK; Houtrow A; Pruitt D
PM R; 2019 Jan; 11(1):38-44. PubMed ID: 29964211
[TBL] [Abstract][Full Text] [Related]
34. Ketamine/midazolam versus etomidate/fentanyl: procedural sedation for pediatric orthopedic reductions.
Lee-Jayaram JJ; Green A; Siembieda J; Gracely EJ; Mull CC; Quintana E; Adirim T
Pediatr Emerg Care; 2010 Jun; 26(6):408-12. PubMed ID: 20502386
[TBL] [Abstract][Full Text] [Related]
35. The impact of botulinum toxin A and abduction bracing on long-term hip development in children with cerebral palsy.
Willoughby K; Ang SG; Thomason P; Graham HK
Dev Med Child Neurol; 2012 Aug; 54(8):743-7. PubMed ID: 22686491
[TBL] [Abstract][Full Text] [Related]
36. Botulinum toxin type A in children and adolescents with severe cerebral palsy: a retrospective chart review.
Mesterman R; Gorter JW; Harvey A; Lockhart J; McEwen-Hill J; Margallo K; Goldie N
J Child Neurol; 2014 Feb; 29(2):210-3. PubMed ID: 23965398
[TBL] [Abstract][Full Text] [Related]
37. Effects of leg muscle botulinum toxin A injections on walking in children with spasticity-related cerebral palsy: a systematic review.
Ryll U; Bastiaenen C; De Bie R; Staal B
Dev Med Child Neurol; 2011 Mar; 53(3):210-6. PubMed ID: 21291464
[TBL] [Abstract][Full Text] [Related]
38. Upper extremity spasticity in children with cerebral palsy: a randomized, double-blind, placebo-controlled study of the short-term outcomes of treatment with botulinum A toxin.
Koman LA; Smith BP; Williams R; Richardson R; Naughton M; Griffin L; Evans P
J Hand Surg Am; 2013 Mar; 38(3):435-46.e1. PubMed ID: 23428186
[TBL] [Abstract][Full Text] [Related]
39. Sonography-guided injection of botulinum toxin A in children with cerebral palsy.
Berweck S; Feldkamp A; Francke A; Nehles J; Schwerin A; Heinen F
Neuropediatrics; 2002 Aug; 33(4):221-3. PubMed ID: 12368994
[TBL] [Abstract][Full Text] [Related]
40. Botulinum toxin A injections and occupational therapy in children with unilateral spastic cerebral palsy: a randomized controlled trial.
Lidman G; Nachemson A; Peny-Dahlstrand M; Himmelmann K
Dev Med Child Neurol; 2015 Aug; 57(8):754-61. PubMed ID: 25808577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
